Germany is suspending routine use of the Oxford-AstraZeneca Covid-19 vaccine for people aged below 60 because of a risk of rare blood clots.

The German medicines regulator found 31 cases of a type of rare blood clot among the nearly 2.7 million people who had received the vaccine in Germany.

Canada earlier suspended use of the AstraZeneca jab in people under 55.

AstraZeneca said international regulators had found the benefits of its jab outweighed risks significantly.

Lookman, Ronaldo, Messi Among 2024 Globe Soccer Awards Nominees

Court Adjourns Falana’s Case Against VDM to January 2025

Alleged Fraud: EFCC Grants Bail to Yahaya Bello’s Co-Defendants, Seeks Adjournment to Nov 27

Body of Late COAS Lagbaja Arrives in Abuja for Burial

Governor Okpebholo Orders Immediate Freeze on Edo State Bank Accounts

NNPCL Signs 10-Year Gas Supply Agreement with Dangote Refinery

See All Trending News